Yurie Hirata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yurie Hirata has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Madoka Higuchi
Department of Renal and Genitourinary Surgery Hokkaido University Graduate School of Medicine Sapporo Japan
2 shared publications- Takahiro Osawa
Department of Urology and Molecular Oncology, Graduate School of Medicine and Dental Sciences, Niigata University, Niigata, Japan
2 shared publications - Hiroki Chiba
Department of Renal and Genitourinary Surgery Hokkaido University Graduate School of Medicine Sapporo Japan
1 shared publication - Hiroshi Kikuchi
Department of Urology Hokkaido University Hospital Sapporo Japan
1 shared publication Keita Sakamoto
Department of Diagnostic and Interventional Radiology Hokkaido University Hospital Sapporo Japan
1 shared publication- Kimihiko Moriya
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan
1 shared publication
Latest Publications
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- 21 May 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (10) , 1140-1146
Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods
Objectives There is no consensus about the follow-up schedule after 5-year cancer-free periods. In this study, we aimed to elucidate the risk factors for the recurrence in patients with non-muscle-invasive bladder cancer who remained cancer free for more than 5 years. Methods Data from six Japanese institutions were retrospectively reviewed. Among the patients with non-muscle-invasive bladder cancer who were treated with transurethral resection of bladder tumor between 1990 and 2013, those who had no recurrence for more than 5 years were included in this study. The Kaplan-Meier method and Cox hazards model were used to estimate recurrence-free survival and to determine the pathologic and clinical factors affecting late recurrence. Results In total, 434 patients were enrolled in this study. Of these patients, 55 patients (12.7%) experienced late recurrence. The median follow-up time was 8.9 years (interquartile range 6.9-11.3 years). Prior history of bladder cancer before the most recent transurethral resection was a significant predictor for late recurrence (hazard ratio 1.99 [95% confidence interval 1.13-3.47], P = 0.019), although other clinical factors including tumor grade, pathologic stage, tumor multiplicity, and current risk classification systems were not associated with late recurrence. Conclusions Late recurrence after a long tumor-free period is not rare and it was not predicted by current risk classification systems. Only prior history of bladder cancer was a significant predictor for late recurrence in this study.
- 21 May 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (10) , 1140-1146
Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods
Objectives There is no consensus about the follow-up schedule after 5-year cancer-free periods. In this study, we aimed to elucidate the risk factors for the recurrence in patients with non-muscle-invasive bladder cancer who remained cancer free for more than 5 years. Methods Data from six Japanese institutions were retrospectively reviewed. Among the patients with non-muscle-invasive bladder cancer who were treated with transurethral resection of bladder tumor between 1990 and 2013, those who had no recurrence for more than 5 years were included in this study. The Kaplan-Meier method and Cox hazards model were used to estimate recurrence-free survival and to determine the pathologic and clinical factors affecting late recurrence. Results In total, 434 patients were enrolled in this study. Of these patients, 55 patients (12.7%) experienced late recurrence. The median follow-up time was 8.9 years (interquartile range 6.9-11.3 years). Prior history of bladder cancer before the most recent transurethral resection was a significant predictor for late recurrence (hazard ratio 1.99 [95% confidence interval 1.13-3.47], P = 0.019), although other clinical factors including tumor grade, pathologic stage, tumor multiplicity, and current risk classification systems were not associated with late recurrence. Conclusions Late recurrence after a long tumor-free period is not rare and it was not predicted by current risk classification systems. Only prior history of bladder cancer was a significant predictor for late recurrence in this study.
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e753
Risk factors of concomitant undescended testis in patients with hypospadias
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e753
Risk factors of concomitant undescended testis in patients with hypospadias